TENAYA THERAPEUTICS INC (TNYA) Forecast, Price Target & Analyst Ratings
NASDAQ:TNYA • US87990A1060
0.8929 USD
+0.03 (+3.98%)
At close: Mar 12, 2026
0.887 USD
-0.01 (-0.66%)
After Hours: 3/12/2026, 8:13:33 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for TENAYA THERAPEUTICS INC (TNYA).
Forecast Snapshot
Consensus Price Target
$9.18
+ 928.11% Upside
Next Earnings Forecast
Release DateMar 24, 2026
PeriodQ4 / 2025
EPS Estimate-$0.12
Revenue Estimate
ChartMill Buy Consensus
84.29%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$9.18
Upside
+ 928.11%
From current price of $0.89 to mean target of $9.18, Based on 14 analyst forecasts
Low
$2.02
Median
$3.06
High
$42.00
Price Target Revisions
1 Month
0.00%
3 Months
-11.27%
Price Target Summary
14 Wall Street analysts provided a forecast for the next 12 months for TNYA. The average price target is 9.18 USD. This implies a price increase of 928.11% is expected in the next year compared to the current price of 0.8929.
The average price target has been revised downward by 11.27% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.29%
TNYA was analyzed by 14 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about TNYA.
In the previous month the buy percentage consensus was at a similar level.
TNYA was analyzed by 14 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-12 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-12-18 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-12-12 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-12-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-10 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-09-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-04-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-03-12 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-12 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-03-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-02-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-18 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-12-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-26 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-07 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-10-18 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-10-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 24, 2026
PeriodQ4 / 2025
EPS Estimate-$0.12
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q55.83%
Number of Analysts10
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
18.49%
Next Earnings Summary
TNYA is expected to report earnings on 3/24/2026. The consensus EPS estimate for the next earnings is -0.12 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 183.32% | N/A 178.19% | N/A 76.62% | N/A 104.32% | N/A 15.05% | N/A 15.08% | |||||||
| EBITDA YoY % growth | -25.72M | -36.43M -41.64% | -69.85M -91.74% | -119.15M -70.58% | -122.506M -2.82% | -107.48M 12.27% | N/A 18.40% | N/A -17.47% | N/A -28.54% | N/A -28.55% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -27.71M | -38.91M -40.42% | -72.81M -87.12% | -125.62M -72.53% | -131.193M -4.44% | -115.948M 11.62% | N/A 18.75% | N/A -7.58% | N/A 106.60% | N/A 5,789.67% | N/A 209.17% | N/A 79.39% | N/A 113.46% | N/A 15.18% | N/A 15.30% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.79 70.82% | -1.67 40.14% | -1.32 20.96% | N/A 53.35% | N/A 23.53% | N/A 118.41% | N/A 2,141.18% | N/A 80.05% | N/A 75.22% | N/A 117.64% | N/A 14.60% | N/A 14.74% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.12 55.83% | -0.13 46.17% | -0.13 5.29% | -0.14 -13.33% | -0.14 -12.72% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -24.378M -47.48% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -22.846M 8.62% | -24.45M 11.21% | -25.844M -7.32% | -27.244M -30.13% | -28.825M -26.17% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
27.36%
EPS Next 5 Year
35.99%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-3.61%
EBIT Next 5 Year
-9.35%
TENAYA THERAPEUTICS INC / TNYA Forecast FAQ
What do analysts expect the price target to be for TENAYA THERAPEUTICS INC (TNYA)?
14 analysts have analysed TNYA and the average price target is 9.18 USD. This implies a price increase of 928.11% is expected in the next year compared to the current price of 0.8929.
Can you provide the upcoming earnings date for TENAYA THERAPEUTICS INC?
TENAYA THERAPEUTICS INC (TNYA) will report earnings on 2026-03-24, after the market close.
What are the consensus estimates for TENAYA THERAPEUTICS INC (TNYA) next earnings?
The consensus EPS estimate for the next earnings of TENAYA THERAPEUTICS INC (TNYA) is -0.12 USD and the consensus revenue estimate is 0 USD.
How many analysts have analysed TENAYA THERAPEUTICS INC (TNYA)?
The number of analysts covering TENAYA THERAPEUTICS INC (TNYA) is 14.